enVVeno Medical Corp (NVNO) stock
NVNONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$5.77+0.00 (0.00%)
Close on Nov 18, 2026Market cap $4.01MP/E –Yield –
enVVeno Medical total assets
Total assets on the balance sheet at the end of each period.
enVVeno Medical's total assets was $19.49M at Sep 30, 2026. For fiscal 2025 it was $29.56M, down 34.2% from the year before. The highest annual figure on record is $57.70M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $29.56M | -34.2% |
| FY2024 | Dec 31, 2024 | $44.95M | -7.6% |
| FY2023 | Dec 31, 2023 | $48.64M | +16.7% |
| FY2022 | Dec 31, 2022 | $41.66M | -27.8% |
| FY2021 | Dec 31, 2021 | $57.70M | +447.5% |
| FY2020 | Dec 31, 2020 | $10.54M | +206.8% |
| FY2019 | Dec 31, 2019 | $3.43M | -3.5% |
| FY2018 | Dec 31, 2018 | $3.56M | +60.7% |
| FY2017 | Dec 31, 2017 | $2.21M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $19.49M | -39.8% |
| Q2 FY2026 | Jun 30, 2026 | $22.66M | -38.0% |
| Q1 FY2026 | Mar 31, 2026 | $26.10M | -35.7% |
| Q4 FY2025 | Dec 31, 2025 | $29.56M | -34.2% |
| Q3 FY2025 | Sep 30, 2025 | $32.35M | -35.8% |
| Q2 FY2025 | Jun 30, 2025 | $36.58M | -10.8% |
| Q1 FY2025 | Mar 31, 2025 | $40.58M | -9.5% |
| Q4 FY2024 | Dec 31, 2024 | $44.95M | -7.6% |
| Q3 FY2024 | Sep 30, 2024 | $50.39M | +79.4% |
| Q2 FY2024 | Jun 30, 2024 | $41.00M | +27.8% |
| Q1 FY2024 | Mar 31, 2024 | $44.83M | +22.4% |
| Q4 FY2023 | Dec 31, 2023 | $48.64M | +16.7% |
| Q3 FY2023 | Sep 30, 2023 | $28.09M | -38.2% |
| Q2 FY2023 | Jun 30, 2023 | $32.09M | -35.7% |
| Q1 FY2023 | Mar 31, 2023 | $36.61M | -32.5% |
| Q4 FY2022 | Dec 31, 2022 | $41.66M | -27.8% |
| Q3 FY2022 | Sep 30, 2022 | $45.46M | -23.2% |
| Q2 FY2022 | Jun 30, 2022 | $49.93M | +17.9% |
| Q1 FY2022 | Mar 31, 2022 | $54.22M | +20.4% |
| Q4 FY2021 | Dec 31, 2021 | $57.70M | +447.5% |
| Q3 FY2021 | Sep 30, 2021 | $59.17M | +740.2% |
| Q2 FY2021 | Jun 30, 2021 | $42.35M | +1034.4% |
| Q1 FY2021 | Mar 31, 2021 | $45.05M | +1526.7% |
| Q4 FY2020 | Dec 31, 2020 | $10.54M | +206.8% |
| Q3 FY2020 | Sep 30, 2020 | $7.04M | +22.5% |
| Q2 FY2020 | Jun 30, 2020 | $3.73M | -48.5% |
| Q1 FY2020 | Mar 31, 2020 | $2.77M | -49.5% |
| Q4 FY2019 | Dec 31, 2019 | $3.43M | -3.5% |
| Q3 FY2019 | Sep 30, 2019 | $5.75M | +5.8% |
| Q2 FY2019 | Jun 30, 2019 | $7.25M | +0.7% |
| Q1 FY2019 | Mar 31, 2019 | $5.49M | +147.8% |
| Q4 FY2018 | Dec 31, 2018 | $3.56M | – |
| Q3 FY2018 | Sep 30, 2018 | $5.44M | – |
| Q2 FY2018 | Jun 30, 2018 | $7.21M | – |
| Q4 FY2017 | Dec 31, 2017 | $2.21M | – |
See a number that looks wrong?